Company intelligence / Profile preview

3D Biomatrix

Carlsbad, California, United States

Ownership: Private
Development stage: Other

Overview

3D Biomatrix specialized in 3D cell culture solutions, including the development of Perfecta3D Hanging Drop Plates, which enabled more physiologically relevant in vitro drug discovery, particularly in oncology research. Their technology facilitated high-throughput, uniform 3D spheroid and co-culture formation for applications including drug toxicity profiling and modeling cancer complexity in vitro. No therapeutic clinical results were reported since the company was a tool provider, not a therapeutic developer.

Therapeutic areas: OncologyOther
Modalities: Device3D cell culture system
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on 3D Biomatrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3D Biomatrix.

Explore the full profile